Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post on LinkedIn:
“At the Lung Cancer Congress, we discussed the latest advancements in targeted therapies and novel immunotherapies.
The progress made over the past 15 years has been truly transformative – what was once a disease measured in months is now measured in years.
As scientific innovation continues, so does the hope for improved outcomes in lung cancer treatment.”
More posts featuring Elvina Almuradova.